balsalazide

(redirected from Giazo)
Also found in: Wikipedia.

balsalazide

 [bal-sal´ah-zīd]
a prodrug of the antiinflammatory mesalamine, to which it is converted in the colon; administered orally as the disodium salt in the treatment of ulcerative colitis.

balsalazide

/bal·sal·a·zide/ (bal-sal´ah-zīd) a prodrug of the antiinflammatory mesalamine, to which it is converted in the colon; administered orally as the sodium salt in the treatment of ulcerative colitis.

balsalazide

[bal-sal′ah-zīd]
a prodrug of the antiinflammatory mesalamine, to which it is converted in the colon; administered orally as the disodium salt in the treatment of ulcerative colitis.

balsalazide

Colazal® Internal medicine An agent that delivers concentrated 5-aminosalicylic acid to the colonic mucosa in Pts with ulcerative colitis. See Ulcerative colitis.

balsalazide

A drug used in the treatment of ULCERATIVE COLITIS. A brand name is Colazide.
Mentioned in ?
References in periodicals archive ?
That win was followed by another gold for the digital sales aid for Giazo from Salix Pharmaceuticals.
Io son Gismonda donna di Salerno che per mio amator qui morta giazo, il fiero padre il trasse a mal governo, el viver dopo lui mi fu d'impazo; lo spirito mio col suo e ne l'inferno, el corpo in questa tomba gli sta in brazo, e fu li salda e si mi strinse amore, che viva e morta sieguo il mio signore.
The company received a letter from the FDA raising the manufacturing deficiency issues for the facility where Giazo is made.
On February 3, 2012 the FDA granted marketing approval for GIAZO (balsalazide disodium) tablets, 1.
The availability of GIAZO provides an additional aminosalicylate-based option for treating ulcerative colitis.
We continue to believe 2010 total Company product revenue will be approximately $334 million, assuming the approval and launch of GIAZO, and that we will be able to generate approximately $0.
The other Bronze was for an iPad sales detail created for the ulcerative colitis medication Giazo.
Three were for a campaign aimed at healthcare professionals for the ulcerative colitis treatment Giazo.
Butt" campaign for Giazo have been awarded top honors at the MM&M (Medical Marketing & Media) Awards presentation held in New York City on October 2, 2013.
Butt" campaign for Giazo and Girls Right of Way campaign for The Coore Foundation have been named as finalists for the upcoming MM&M (Medical Marketing & Media) Awards.
Butt campaign for Giazo, and 2 Girls Right of Way campaigns for The Coore Foundation were recognized at The IndiGENIUS Awards ceremony held in Barcelona, Spain, on May 21, 2013.
375 g, GIAZO (TM)(balsalazide disodium) tablets, COLAZAL (balsalazide disodium) Capsule, METOZOLV ODT (metoclopramide HCl), RELISTOR (methylnaltrexone bromide) Subcutaneous Injection, FULYZAQ (TM)(crofelemer) delayed-release tablets, SOLESTA, DEFLUX, PEPCID (famotidine) for Oral Suspension, DIURIL (Chlorothiazide) Oral Suspension, AZASAN (Azathioprine) Tablets, USP, 75/100 mg, ANUSOL-HC 2.